Gabriel Aballay Soteras

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

Massimo Iavarone, Federica Invernizzi, Carolin Czauderna et al. · American Journal of Transplantation · 2019 · 86 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study

Massimo Iavarone, Federica Invernizzi, Tommy Ivanics et al. · Liver Transplantation · 2021 · 36 citations

Medicine, Oncology, Pharmacotherapy +17

Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry

Manuel Mendizábal, Viviana Tagliafichi, Fernando Rubinstein et al. · Annals of Hepatology · 2019 · 20 citations · Full text

Medicine, Surgery, Hepatology +16

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Leonardo Gomes da Fonseca et al. · Liver International · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV‐infected patients in a real‐life cohort from Latin America

Manuel Mendizábal, Leila Haddad, Patricia Gallardo et al. · Journal of Medical Virology · 2017 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15